Responses
Prognosis
Systematic review
Carrying one or two reduced-function CYP2C19 alleles is associated with an increased risk of major adverse cardiovascular events in people undergoing percutaneous coronary intervention and treated with clopidogrel
Compose a Response to This Article
Other responses
No responses have been published for this article.